The LuCaP TMA from PDX contain 42 patient tissues (24 are from adenocarcinoma, 13 from CRPC, 4 patients are from t-NEPC and one AR null, NE null prostate cancer group often referred as double negative stage) in triplicate. This evidence concerns the gene AR and adenocarcinoma.